Science Explorer Back to mapMap
Discussion
Researcher · Finlay Institute · Cuba

Carmen Valenzuela‐Silva

Carmen Valenzuela‐Silva publishes mostly in Infectious Diseases, Molecular Biology and Immunology, on topics such as SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches and COVID-19 Clinical Research Studies.

ORCID 0000-0002-1082-2089 OpenAlex
World rank
#1,399,647
of 7,710,434 ranked researchers
Rank in Cuba
#46
of 7,334
Works
48
Citations
1.4k
Citations per work
28.6
h-index
23
i10-index 33Top 18% in Infectious Diseases
Carmen Valenzuela‐Silva

What does Carmen Valenzuela‐Silva research?

Carmen Valenzuela‐Silva's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (8%).

Everything else: 21 works · 43.7% of their workHealth Sciences: 18 works · 37.2% of their workMedicine: 18 works · 37.2% of their workInfectious Diseases: 10 works · 20.4% of their workEpidemiology: 3 works · 6.3% of their workSurgery: 3 works · 5.6% of their workOncology: 2 works · 4.9% of their workLife Sciences: 9 works · 19.1% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 10.6% of their workMolecular Biology: 5 works · 10.6% of their workImmunology and Microbiology: 4 works · 8.5% of their workImmunology: 4 works · 8.5% of their workTHEIR WORKCarmenValenzuela‐Silva48works
Life Sciences19%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2143.7%
    1. Medicine1837.2%
    1. Biochemistry, Genetics and Molecular Biology510.6%
    2. Immunology and Microbiology48.5%
  1. 1Infectious Diseases20% of their works
  2. 2Molecular Biology11% of their works
  3. 3Immunology8% of their works
  4. 4Epidemiology6% of their works
  5. 5Surgery6% of their works
  6. 6Oncology5% of their works

Research topics

Which keywords describe Carmen Valenzuela‐Silva's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Coronavirus, Vaccine, Epidemiology, Immune Response, Diabetes and Wound Healing.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. ACE2 Receptor262 topics
  2. SARS-CoV-2262 topics
  3. Coronavirus181 topic
  4. Vaccine181 topic
  5. Epidemiology173 topics
  6. Immune Response122 topics
  7. Diabetes102 topics
  8. Wound Healing102 topics
  9. Clinical Characteristics81 topic
  10. Epitope Prediction81 topic
  11. Peptide-MHC Binding81 topic
  12. Thrombosis81 topic
  13. COVID-19 Vaccine51 topic
  14. Foot Ulcers51 topic
  15. Innate Memory51 topic
  16. Macrophages51 topic
  17. Prevention51 topic
  18. Regeneration51 topic
  19. Trained Immunity51 topic
  20. Vaccine Hesitancy51 topic
  21. Hepatitis C Virus41 topic
  22. Treatment41 topic

Where does Carmen Valenzuela‐Silva work?

Carmen Valenzuela‐Silva's main affiliation in the publication record is Finlay Institute, Cuba.

How many publications and citations does Carmen Valenzuela‐Silva have?

OpenAlex counts 48 works and 1,371 citations for Carmen Valenzuela‐Silva, an h-index of 23, ranking #1,399,647 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Carmen Valenzuela‐Silva

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carmen Valenzuela‐Silva. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.